HFS
ITOS

Hantz Financial Services’s iTeos Therapeutics ITOS Stock Holding History

Hantz Financial Services’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$1K – 2393
2025
Q2 		$1K Hold
100
– – ﹤0.01% 2091
2025
Q1 		$1K Hold
100
– – ﹤0.01% 1532
2024
Q4 		$1K Hold
100
– – ﹤0.01% 1041
2024
Q3 		$1K Hold
100
– – ﹤0.01% 1022
2024
Q2 		$1K Hold
100
– – ﹤0.01% 1006
2024
Q1 		$1K Hold
100
– – ﹤0.01% 1129
2023
Q4 		$1K Buy
+100
New +$991 ﹤0.01% 1077

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hantz Financial Services's ITOS Position: Q3 2025 in Review

Hantz Financial Services sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 100 shares — an estimated $1K sold.

Hantz Financial Services first reported a position in ITOS in Q4 2023 and held it in 7 quarters. The position peaked at $1K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Hantz Financial Services reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Hantz Financial Services sold 100 iTeos Therapeutics shares in Q3 2025, an estimated $1K.
  • Hantz Financial Services first reported a position in iTeos Therapeutics in Q4 2023 and held it in 7 quarters.
  • Hantz Financial Services's iTeos Therapeutics position peaked at $1K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Hantz Financial Services's 13F filing for Q3 2025, filed 5 Nov 2025.